Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 September 2024 | Story Lunga Luthuli | Photo Supplied
2024 - 2025 CSRC elections
The UFS’s recent pioneering of live election results during the 2024/2025 CSRC elections drove unprecedented student engagement.

The University of the Free State (UFS) has proven its commitment to innovation and student engagement with the recent 2024/2025 Campus Student Representative Council (CSRC) elections, which were held online and featured real-time results projection across all three campuses. The elections, held from 20 to 22 August 2024, marked a significant milestone for the institution, setting a precedent in the national higher education landscape.

Dr Grey Magaiza, Chairperson of the UFS Elections Logistics Committee (ELC), provided insight into the planning process that went into making the elections a success: “Planning for an institutional CSRC election is a very demanding process,” he explained. “Multiple stakeholders have to be appraised of the project, as it has multiple implications for the institution. The voting is the last phase in a long list of actions that a capable team must support.”

One of the most notable aspects of this year’s elections was the introduction of real-time results, a first for any institution in South Africa. Despite the challenges that came with being pioneers in this area, the ELC managed to overcome them through rigorous scenario planning and extensive negotiations. “This is a huge milestone, but it did not come without its own challenges,” Dr Magaiza said. “We had to engage in multiple negotiations with numerous process owners. The debates that ensued only sharpened our ability to observe potential blind spots.”

Students embrace live voting

The transition from traditional online voting to a system with live results was met with enthusiasm by the student body. “Students have always been for online elections. The majority of students we talked to loved the live results format,” Dr Magaiza said. The decision to share the live results link with the entire student body, despite initial requests for it to be limited to party agents, was particularly well-received, further enhancing transparency and engagement.

Security and accuracy were also top priorities for the ELC, with advanced IT processes in place to ensure a seamless voting experience. Each student was provided with a unique one-time PIN (OTP) sent to both their UFS email and cellphone, and the system was designed to cater to the specific needs of each campus.

The live results projection, which updated every five minutes, not only drove massive voter turnout across all campuses but also fostered a more dynamic and engaging election atmosphere. “The turnout was massive across all three campuses, surpassing the previous year’s figures,” Dr Magaiza said.

Reflecting on the success of the elections, Dr Magaiza emphasised the importance of collaboration and preparation. He also expressed confidence that the UFS model could serve as an example for other institutions in South Africa. “Live results enhance transparency and acceptance of the election results. As UFS, we have not had a single objection with regards to the first-past-the-post election results,” he concluded.

The 2024/2025 CSRC Elections at the UFS have not only set a new standard within the university, but have also highlighted the potential for innovation in student governance across the country.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept